Navigation Links
Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability
Date:10/28/2008

Boston Healthcare grows to meet increasing global demand for health

economics and market access support

BOSTON, Oct. 28 /PRNewswire/ -- Boston Healthcare Associates, Inc. today announced the appointment of Adam Barak as Vice President.

Mr. Barak brings 16 years of pricing and reimbursement experience, including the development of global pricing and reimbursement strategies for drugs, medical devices, and diagnostics in a wide range of therapeutic areas including oncology, pulmonary medicine, gastroenterology, cardiovascular medicine, neurology, and critical care.

"Adam's appointment demonstrates Boston Healthcare's continued commitment to expanding the scope and reach of our services," said Joseph Ferrara, President of Boston Healthcare. "His wealth of experience in pricing and reimbursement will strengthen our position internationally, and provide the expertise and leadership we need to serve our clients more effectively worldwide. Adam is a strong addition to the executive management team and an asset to our global strategy."

Mr. Barak joined GlaxoWellcome's International Pricing & Reimbursement division in 1996. In 1997, Mr. Barak became Head of European Pricing, managing the regional function and developing international pricing strategies for four of the seven GlaxoWellcome therapy areas, including European pricing strategies for CNS, cardiovascular, oncology, anesthesiology and diabetes drugs. In 2001, Mr. Barak joined Oxford GlycoSciences as International Pricing and Reimbursement Manager, developing global pricing, reimbursement, and market access strategy for Zavesca, the company's first pharmaceutical launch. In 2002, Mr. Barak established his own consultancy, ABPPC Ltd, and formed a global network of consultants that provide the international pharmaceutical and health care community with specialized support for pricing, reimbursement, and market access. The network covers 22 countries, and is represented by Boston Healthcare in the UK and US.

About Boston Healthcare

Boston Healthcare assists emerging and established biopharmaceutical, medical device and diagnostic companies in gaining a competitive advantage in the health care marketplace by helping them unlock the value of innovative drugs, devices, and diagnostics. These companies rely on Boston Healthcare to create opportunities, navigate complexity, grow their businesses, and achieve objectives through reimbursement, business development, and market strategies. Clients draw on Boston Healthcare's unique approach to gain a real-world edge in a highly competitive health care environment.

Contact:

Michal Taton

Boston Healthcare

(617) 912-5119

mtaton@bostonhealthcare.com


'/>"/>
SOURCE Boston Healthcare Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Boston Scientific Announces Results for Third Quarter Ended September 30, 2008
2. Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet
3. Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
4. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
5. Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
6. Boston Scientific to Participate in UBS Global Life Sciences Conference
7. Boston Scientific Announces Court Decision
8. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
9. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
10. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
11. TechCFO Adds Gary Strickland as Partner in Boston Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):